Immunovant
IMVT
IMVT
40 hedge funds and large institutions have $194M invested in Immunovant in 2020 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
2.64% more ownership
Funds ownership: 20.58% → 23.21% (+2.6%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
40
Holding in Top 10
2
Calls
$412K
Puts
–
Top Buyers
| 1 | +$7.35M | |
| 2 | +$7.11M | |
| 3 | +$5.27M | |
| 4 |
BlackRock
New York
|
+$4.72M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$3.89M |
Top Sellers
| 1 | -$7.93M | |
| 2 | -$7.8M | |
| 3 | -$2.88M | |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
-$1.61M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$1.4M |